Core Laboratories N.V.

符号: CLB

NYSE

17.09

USD

今天的市场价格

  • 19.1648

    市盈率

  • -0.3545

    PEG比率

  • 801.52M

    MRK市值

  • 0.00%

    DIV收益率

Core Laboratories N.V. (CLB) 财务报表

在图表中,您可以看到 的动态默认数字 Core Laboratories N.V. (CLB). 的默认数据。公司收入显示 NaN M 的平均值,即 NaN % 增长率。整个期间的平均毛利润为 NaN M,即 NaN %. 平均毛利率为 NaN %. 公司去年的净收入增长率为 NaN %,等于 NaN % % 整个公司历史的平均增长率.,

资产负债表

深入分析 Core Laboratories N.V. 的财务轨迹,我们可以看到其平均资产增长率。有趣的是,这一增长率为 ,反映了公司的高点和低点。与季度相比,这一数字调整为. 回顾过去一年,总资产变化为 NaN. 股东权益总额所体现的股东价值是以报告货币计算的 NaN. 这方面的年同比变化率为 NaN%.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995

balance-sheet.row.cash-and-short-term-investments

015.115.417.7
13.8
11.1
13.1
14.4
14.8
22.5
23.4
25.1
19.2
29.3
133.9
181
36.1
25.6
54.2
13.7
16
16.8
14.9
14.5
12.9
18.1
8.2
10.5
2.9
4.3

balance-sheet.row.short-term-investments

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.net-receivables

0123.1106.996.8
83.2
131.6
129.2
133.1
114.3
145.7
197.2
201.3
184.8
170.8
154.7
133.8
144.3
137.2
112.1
99.1
95.4
107.9
100.6
104.9
110.9
81.1
84.3
67.5
28
22.5

balance-sheet.row.inventory

071.760.445.4
38.2
50.2
45.7
33.3
33.7
40.9
43.4
46.8
49.3
53.2
34
32.2
34.8
29.4
30.2
29.1
29.4
31.4
34.5
41.1
34.1
24.5
18.9
12.5
9.5
8.1

balance-sheet.row.other-current-assets

013.228.929.1
30.7
28.4
43
26.6
23.6
29.5
37.9
30.6
43.6
27.5
26.7
43.5
26.8
28.5
29.1
11.3
10.7
10.9
25.7
18.9
17.3
16.7
15
7.2
2.2
1.5

balance-sheet.row.total-current-assets

0223.1211.7189.1
165.8
221.2
231
207.4
186.5
238.5
301.8
303.9
296.9
280.8
349.3
390.5
242
220.7
225.6
153.2
151.6
167
175.7
179.3
175.2
140.4
126.4
97.7
42.6
36.4

balance-sheet.row.property-plant-equipment-net

0153.5157.4172.3
181.7
199.2
122.9
123.1
129.9
143.2
149
138.8
125.4
115.3
104.2
98.8
103.5
93
87.7
81.3
79.6
94.8
95.5
97.6
83.3
64.5
68.2
53.6
27.7
20

balance-sheet.row.goodwill

099.499.499.4
99.4
213.4
219.4
179
179
178.2
164.5
163.3
163.3
162.8
154.2
148.6
148.6
138.8
132.6
0
0
140.1
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

06.97.58.1
8.6
17.4
13.1
9.4
9.9
10
10.6
10.9
8.7
8.2
8.7
6.5
7
7
6.6
139.3
139.7
150.3
142.4
151.3
147.9
150.3
149.5
82.8
8.4
8.5

balance-sheet.row.goodwill-and-intangible-assets

0106.4209.2219.5
221.1
354.2
294.9
254.3
256.7
243.5
224.8
218.3
214.2
171
162.9
155.1
155.6
145.8
139.2
139.3
139.7
150.3
142.4
151.3
147.9
150.3
149.5
82.8
8.4
8.5

balance-sheet.row.long-term-investments

04.84.54.2
4.1
4
3.8
3.6
3.2
2.7
2.3
1.9
1.9
0
0
-14.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

069.268.670.5
72.8
67.3
11.3
10.7
20.6
11.7
3.9
4.5
13.2
13.7
0
14.4
27.4
26
33
11.5
7.7
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

029.4-73-74.6
-76.9
-71.3
-15
-14.3
-23.8
-14.4
-6.2
-6.4
-15.1
24.4
19.6
13.7
9.1
19.2
15.7
9.2
10.2
9.3
7.7
11.3
4.1
5.9
4.5
3.9
1
0.4

balance-sheet.row.total-non-current-assets

0363.3366.7391.8
402.7
553.4
417.9
377.4
386.6
386.7
373.8
357.1
339.6
324.3
286.7
267.6
295.6
284.1
275.7
241.4
237.2
254.4
245.5
260.2
235.4
220.7
222.2
140.3
37.1
28.9

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

0586.4578.4580.9
568.6
774.7
648.8
584.8
573.1
625.3
675.7
661
636.5
605.1
636
658.2
537.7
504.8
501.2
394.6
388.8
421.4
421.2
439.5
410.6
361.1
348.6
238
79.7
65.3

balance-sheet.row.account-payables

033.545.829.7
23
35.6
41.2
41.7
33.7
33.5
47.1
50.8
55.2
57.6
44.7
33
41.6
39.9
37.5
32.6
28.6
27.1
25.4
19.7
25.2
18.2
18.5
14.2
5.9
5.4

balance-sheet.row.short-term-debt

010.211.712.3
11.4
11.8
10.4
-17.1
-15.7
-14.1
-11
-10.9
0
2.3
147.5
23.6
0
3
2.8
2.5
3
3.4
1.1
0.5
0.9
1.7
18.6
3.5
4.4
2.7

balance-sheet.row.tax-payables

07.37.912.4
14.9
14.7
10.4
8.1
21.5
11.2
19.5
21.4
21.3
9.4
28.8
23.6
7.9
0
8.7
0
0
7.4
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

0163.1210.7237.9
315.5
369.9
289.8
227
216.5
431
356
267
234
223.1
8.9
209.1
238.7
300
300
86.1
110.2
124.7
88
95.1
82
82.9
68.2
70.6
11.6
11.9

Deferred Revenue Non Current

030.531.8-24.3
-20.6
-27.3
1.4
-5.3
-6.3
-4.9
-7.2
-8.9
-6.8
24.1
21.2
16.9
8.1
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

039.739.640.9
49.8
50.8
33.7
63.3
70.3
87.3
84.8
85
71.4
58.3
66.9
33.3
54.1
46
41.8
31.2
33.2
28.3
21.8
16.6
25.4
27.2
24.1
24.4
7
6.1

balance-sheet.row.total-non-current-liabilities

0268.5286.3329.1
403.3
480.9
385.4
331.1
313.7
528.2
449.8
355.8
308.1
286
64.3
270
281.6
343.1
339
109.7
130
138.2
112.6
123.1
105.3
103.8
89.3
80.6
14.8
13.9

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

042.15061.6
67.5
76.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

0356.6389.4419.9
493
592.5
487.9
436.1
417.8
649
581.7
491.6
448.6
423.5
343.7
376.4
377.3
441.2
427.9
179.3
197.4
199.9
162.7
163.1
156.9
150.9
150.5
122.7
32.1
28.1

balance-sheet.row.preferred-stock

0000
0
0
4.1
3.9
3.9
5.4
6.4
6.1
5.7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

00.51.21.2
1.1
1.1
1.1
1.1
1.1
1.1
1.2
1.2
1.2
1.4
1.4
1.4
1.4
1.3
1.4
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0
0
0
0

balance-sheet.row.retained-earnings

0120.885.968.3
50.5
160.5
156.1
173.9
188
219.2
415.9
415.9
361.3
283.7
537
469.5
406.2
62.5
224.1
141.4
110.2
97.9
79.2
88.3
68.6
46.6
44.3
26.9
11.7
4.6

balance-sheet.row.accumulated-other-comprehensive-income-loss

0-5-3.8-10.1
-7.2
-6.3
-5.5
-8.4
-9.8
-10.5
-11.9
-8.6
-8.4
-1.7
-6.2
0
-4.9
0.2
-2.1
-0.9
-2.5
-77.8
-64
-56.4
-45
-35.3
-19.8
-16.1
-8.1
-2.9

balance-sheet.row.other-total-stockholders-equity

0108.6105.6101.6
31.2
26.8
4.9
-21.8
-27.9
-238.9
-317.6
-245.2
-171.8
-105.4
-242.7
-191.5
-244.6
-1.9
-151.7
73.3
82.1
199.8
242.4
243.1
227.7
197.1
172.5
103.3
43.8
35.4

balance-sheet.row.total-stockholders-equity

0224.8189161
75.6
182.1
160.9
148.7
155.3
-23.7
94
169.4
187.9
177.9
289.5
279.4
158.2
62.1
71.8
214.3
190.3
220.4
258.1
275.6
251.9
208.9
197
114.1
47.4
37.1

balance-sheet.row.total-liabilities-and-stockholders-equity

0586.4578.4580.9
568.6
774.7
648.8
584.8
573.1
625.3
675.7
661
636.5
605.1
636
658.2
537.7
504.8
501.2
394.6
388.8
421.4
421.2
439.5
410.6
361.1
348.6
238
79.7
65.3

balance-sheet.row.minority-interest

054.74.6
4.1
4.3
4.1
3.9
3.9
5.4
6.4
6.1
5.7
3.8
2.8
2.4
2.2
1.5
1.4
1.1
1.1
1.1
0.3
0.8
1.9
1.3
1.1
1.2
0.2
0.1

balance-sheet.row.total-equity

0229.8193.7165.6
79.6
186.4
165
152.6
159.2
-18.3
100.4
175.5
193.6
181.7
292.3
281.8
160.3
63.6
73.3
215.3
191.4
221.5
258.5
276.4
253.7
210.2
198.1
115.3
47.6
37.2

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

04.84.54.2
4.1
4
3.8
3.6
3.2
2.7
2.3
1.9
1.9
0
0
-14.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-debt

0215.4222.4250.3
327
381.8
289.8
227
216.5
431
356
267
234.1
225.4
156.4
209.1
238.7
303
302.8
88.6
113.2
128.1
89.2
95.6
82.9
84.6
86.8
74.1
16
14.6

balance-sheet.row.net-debt

0200.3207232.6
313.2
370.7
276.7
212.6
201.7
408.5
332.6
241.9
214.8
196.1
22.5
28.1
202.5
277.4
248.5
74.9
97.2
111.4
74.3
81.2
70
66.5
78.6
63.6
13.1
10.3

现金流量表

在 Core Laboratories N.V. 的财务状况中,自由现金流在过去一段时间内发生了显著变化,呈现出 NaN 的转变。该公司最近通过发行 NaN 扩大了股本,与上一年相比出现了NaN 的差异. 公司的投资活动产生了现金使用净额,按报告货币计算达到NaN. 与上一年相比, NaN 发生了变化. 在同一时期,公司记录了 NaN, NaN 和 NaN,这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为NaN,同比差异为NaN. 此外,公司还将NaN 用于向股东分红。与此同时,该公司还采取了其他财务措施,即 NaN,这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起,全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995

cash-flows.row.net-income

036.719.720.2
-96.9
93.7
79.8
83.1
63.9
114.9
258.6
243.2
216.6
184.6
145.4
114.1
143.6
121.1
82.7
31.7
12.3
18.7
-9.1
20.6
19.2
3.4
20
15.4
7.7
5.1

cash-flows.row.depreciation-and-amortization

015.817.218.5
20.9
22.6
23.1
24.9
26.9
27.5
26.7
25.5
22.9
23.3
23.3
24.3
21.8
19.5
17.7
17.1
17.4
23.5
20.1
22.5
19.2
18.7
16.5
11
4.6
3.1

cash-flows.row.deferred-income-tax

0-10.80.46
-12.2
-36.3
1.8
9
-14.4
-0.1
4.7
6.8
3.6
-6.5
-10.1
25.6
-1.4
6.1
8.1
0.1
-2.7
-1.7
-1.8
0
-0.9
-1.8
-5.2
0
0
0

cash-flows.row.stock-based-compensation

0147.819.1
7.4
20.9
34.2
22.9
22.1
21.3
20.5
20.5
18.4
17.2
8.5
5.9
4.7
-9.6
-1.4
0
0
0
0
0
0
-0.6
3.8
0
0
0

cash-flows.row.change-in-working-capital

0-28.8-9.6-11.5
35.1
-10.8
-9.9
-9.4
35.2
47
-6.7
6.6
-23.4
-21
22.2
-2
-12.3
-17.2
6.8
8.1
3.4
12.1
9
-14.7
-29.6
-15.1
-28.9
-28.1
-4.1
-0.5

cash-flows.row.account-receivables

0-2.6-10.1-13.5
46.4
-3.2
2.3
-18.6
31.6
49.3
3.5
-16.3
-16.7
-12.1
-22.4
10
-5
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

0-13-14.9-4.5
1.5
-3.9
-10.4
0.4
6.2
3
2.9
1.3
3.2
-16
-2.4
1.8
-5.6
1
-4.1
-3
-0.9
4.1
6.6
-2.2
-9.3
-12
-2.8
-1.3
-0.9
1

cash-flows.row.account-payables

0-12.915.46.6
-12.8
-3.8
-1.8
8.7
-1
-13.4
-3
-6.3
-3.7
12
11.7
-17.5
2.8
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

0-0.300
0
0
0
0
-1.6
8
-10
27.9
-6.3
-4.9
35.3
-13.8
-1.7
-18.2
11
11.1
4.3
8
2.5
-12.5
-20.3
-3.1
-26.1
-26.8
-3.2
-1.5

cash-flows.row.other-non-cash-items

0-2.1-10.5-15.8
103.7
-0.5
-17.2
-6.3
-1.7
8.5
-0.4
-4.4
-0.9
6.6
16.6
13.9
-1.2
-3.8
5.1
17.9
23.8
8.2
22.7
-0.2
-0.6
-0.7
4.2
-0.2
0.6
0

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-10.6-10.2-13.5
-11.9
-22.3
-21.7
-18.8
-11.7
-24.3
-37.4
-38.9
-32.8
-30.1
-27.8
-17.5
-31.3
-24.1
-24.7
-19.1
-10.9
-23
-19.1
-29
-32.8
-19.1
-27
-15.3
-6.3
-2.3

cash-flows.row.acquisitions-net

00.50.20.9
1.5
3
-47.3
0
-1.2
-13.8
-1.2
-0.1
-0.9
-18.8
-9
0
-11.5
-7.3
0
0
-1.8
-13
-8
-12.8
0
0
0
0
0
0

cash-flows.row.purchases-of-investments

00013.5
0
-1.9
-1.3
-2.1
-2.5
-2.9
-4.3
-6.6
-3.3
0
0
-1.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.sales-maturities-of-investments

0000.7
0
22.3
22.9
0
0
0
0
1.4
0.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.2
0

cash-flows.row.other-investing-activites

03.46.1-11.8
18.2
-6.8
-23.2
-18.5
-11
-22.9
-36.6
-37.9
-29.9
-33.2
-29.6
-16.9
-29.6
11.5
1.1
2.7
18.6
-0.2
1.8
1
4.4
29.1
9
-76.8
-4.3
-8

cash-flows.row.net-cash-used-for-investing-activites

0-6.7-3.9-10.2
7.9
-5.7
-70.6
-20.6
-14.7
-39.7
-42.1
-43.2
-34
-52
-38.6
-18.5
-41.1
-20
-23.6
-16.4
5.9
-36.1
-25.3
-40.8
-28.4
10
-18
-92.1
-10.4
-10.3

cash-flows.row.debt-repayment

0-10.3-131-226
-102
-123
-114
-130
-316.2
-139.7
-128.2
-134
-112.3
-348.6
-82.3
0
-61.4
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-issued

0-4.1-0.460
56
138
178
140
197.2
215
217
167.1
121
417.7
0.3
0
6.2
18.5
71.4
8.2
8.5
1.5
0.6
3
3.1
1.9
1.7
0
0
0

cash-flows.row.common-stock-repurchased

0-2.2-3.9-8.3
-2.8
-3.3
-7.5
-16.9
-7.2
-159.7
-264.4
-227.2
-175.7
-61.8
-92.5
-9.4
-31.7
-181.8
-251.1
-41.4
-51.3
-58
-9
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

0-1.9-1.9-1.8
-12.4
-97.6
-97.3
-97.1
-95.1
-94.2
-89.1
-58.6
-53
-46
-40
-26.7
-27.6
0
0
0
0
0
0
0
0
0
0
0
0
-0.4

cash-flows.row.other-financing-activites

0-0.1113.8153.6
-1.8
0
-1.8
140
96.5
213.3
218.5
170.8
127.7
199.8
0.3
17.6
17.2
29
123.5
-27.5
-17.5
33.6
-6.8
11.5
11.9
-6.4
5.2
101.6
0
4.6

cash-flows.row.net-cash-used-provided-by-financing-activities

0-18.4-23.4-22.5
-63
-85.9
-42.5
-104.1
-124.9
-180.3
-263.1
-249.1
-213.3
-256.7
-214.4
-18.4
-103.6
-134.3
-56.2
-60.7
-60.3
-22.9
-15.2
14.5
15.1
-4.5
6.9
101.6
-0.4
4.2

cash-flows.row.effect-of-forex-changes-on-cash

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

0-0.3-2.33.9
2.7
-2
-1.3
-0.4
-7.7
-0.9
-1.7
5.9
-10.1
-104.5
-47.2
144.9
10.5
-28.6
40.5
-2.3
-0.2
1.9
0.4
1.9
-6.1
9.9
-4.5
7.6
-2
1.6

cash-flows.row.cash-at-end-of-period

015.115.417.7
13.8
11.1
13.1
14.4
14.8
22.5
23.4
25.1
19.2
29.3
133.9
181
36.1
25.6
54.2
13.7
16
16.8
14.9
14.5
12.9
18.1
8.2
10.5
2.9
4.3

cash-flows.row.cash-at-beginning-of-period

015.417.713.8
11.1
13.1
14.4
14.8
22.5
23.4
25.1
19.2
29.3
133.9
181
36.1
25.6
54.2
13.7
16
16.2
14.9
14.5
12.5
19
8.2
12.7
2.9
4.9
2.7

cash-flows.row.operating-cash-flow

024.82536.6
57.9
89.5
111.8
124.3
131.9
219.1
303.4
298.1
237.2
204.1
205.8
181.9
155.2
125.7
120.3
74.8
54.2
60.9
41
28.3
7.3
4.5
6.6
-1.9
8.8
7.7

cash-flows.row.capital-expenditure

0-10.6-10.2-13.5
-11.9
-22.3
-21.7
-18.8
-11.7
-24.3
-37.4
-38.9
-32.8
-30.1
-27.8
-17.5
-31.3
-24.1
-24.7
-19.1
-10.9
-23
-19.1
-29
-32.8
-19.1
-27
-15.3
-6.3
-2.3

cash-flows.row.free-cash-flow

014.214.723
46
67.3
90.1
105.5
120.2
194.8
266
259.2
204.4
174
178
164.3
123.9
101.6
95.6
55.7
43.3
37.9
21.8
-0.7
-25.6
-14.6
-20.4
-17.2
2.5
5.4

利润表行

Core Laboratories N.V. 的收入与上期相比变化了 NaN%。据报告, CLB 的毛利润为 NaN。该公司的营业费用为 NaN,与上年相比变化了 NaN%. 折旧和摊销费用为 NaN,与上一会计期间相比变化了 NaN%. 营业费用报告为 NaN,显示NaN% 的同比变化。 销售和营销费用为 NaN, 其中 NaN% 与上年相比发生了变化。 基于近期数据的EBITDA为 NaN,同比增长NaN%. 营业收入为 NaN,与上年相比变化了NaN%. 净利润的变化率为 NaN%。去年的净收入为NaN.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995

income-statement-row.row.total-revenue

0509.8489.7470.3
487.3
668.2
700.8
659.8
594.7
797.5
1085.2
1073.5
981.1
907.6
794.7
695.5
780.8
670.5
575.7
483.5
427.4
405.6
364.7
376.6
336.1
303.7
286.2
214.9
105.4
80.1

income-statement-row.row.cost-of-revenue

0415.7410.8386.4
395.6
518.2
520.1
499.2
469.5
560.1
692
688.4
644.7
593.4
513.8
457.8
514.8
449.2
407.1
368.1
336.4
326.9
301.3
293.3
268.7
245.4
220.5
170.5
84.7
64.2

income-statement-row.row.gross-profit

09478.983.8
91.6
150
180.8
160.6
125.2
237.4
393.3
385.1
336.3
314.3
280.9
237.8
266.1
221.3
168.6
115.3
91
78.7
63.4
83.3
67.4
58.3
65.7
44.4
20.7
15.9

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

00-0.75.6
-1.8
-5.3
0.7
-0.5
0.3
-3.7
-1.1
0.3
4.1
22.4
20.9
20.6
28.5
3.7
12
16.6
16.4
22.6
22.5
27.8
19.2
18.7
16.5
11
4.6
3.1

income-statement-row.row.operating-expenses

040.337.444.2
34
48
62.9
47.7
39.4
49.7
45.7
52
43.2
63.5
53.9
51
60.2
37.5
45
54.4
44.5
45.4
42.7
43.7
32.8
31
24.9
17
8.2
5.8

income-statement-row.row.cost-and-expenses

0456448.2430.6
429.7
566.2
583
546.9
508.9
609.8
737.6
740.4
687.9
656.9
567.7
508.8
575
486.7
452.1
422.5
380.9
372.3
344
337
301.4
276.4
245.4
187.5
92.9
70

income-statement-row.row.interest-income

0011.69.2
14.4
14.7
0
0
0
0.1
0.4
0.8
0.3
0
0
0
0.8
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.interest-expense

013.411.69.2
14.4
14.7
13.3
10.7
11.6
12.4
10.6
9.3
8.8
10.9
15.8
15.5
6.4
0
0
0
0
7.9
0
0
0
0
0
0
0
0

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-13-11.6-9.2
-147
-14.7
0.7
-0.5
0.3
-26.6
-1.1
0.3
4.1
-1
-1.9
-15.5
8.3
14.6
5
-6.2
0.8
0.9
-2.4
-8.2
0.9
-14.4
-0.9
1.1
0.2
0.1

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

00-0.75.6
-1.8
-5.3
0.7
-0.5
0.3
-3.7
-1.1
0.3
4.1
22.4
20.9
20.6
28.5
3.7
12
16.6
16.4
22.6
22.5
27.8
19.2
18.7
16.5
11
4.6
3.1

income-statement-row.row.total-operating-expenses

0-13-11.6-9.2
-147
-14.7
0.7
-0.5
0.3
-26.6
-1.1
0.3
4.1
-1
-1.9
-15.5
8.3
14.6
5
-6.2
0.8
0.9
-2.4
-8.2
0.9
-14.4
-0.9
1.1
0.2
0.1

income-statement-row.row.interest-expense

013.411.69.2
14.4
14.7
13.3
10.7
11.6
12.4
10.6
9.3
8.8
10.9
15.8
15.5
6.4
0
0
0
0
7.9
0
0
0
0
0
0
0
0

income-statement-row.row.depreciation-and-amortization

015.817.218.5
20.9
22.6
23.1
24.9
26.9
27.5
26.7
25.5
22.9
23.3
23.3
24.3
21.8
19.5
17.7
17.1
17.4
23.5
20.1
22.5
19.2
18.7
16.5
11
4.6
3.1

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

053.841.545.3
55.8
96.7
118.6
112.4
86.2
161.1
346.5
333.4
297.3
250.8
226.9
186.8
206.7
183.8
123.6
60.9
46.5
33.3
20.8
36.6
34.7
27.3
40.8
27.4
12.5
10.1

income-statement-row.row.income-before-tax

040.83036.1
-91.2
82
105.3
101.7
74.6
148.7
335.9
324.1
288.5
238.8
209.1
171.3
208.6
181.3
117.8
46.6
38.2
25.6
13.2
28.7
27.4
5.1
33.7
22
11.4
7.3

income-statement-row.row.income-tax-expense

04.210.315.9
5.9
-12.3
25.4
18.6
10.7
33.8
77.3
80.9
71.8
54.2
63.7
57.2
65
60.2
35.1
14.9
10.2
6.9
5.5
8
8.2
1.7
10.1
6.6
3.7
2.2

income-statement-row.row.net-income

036.719.519.7
-97.1
102
79.5
83.1
63.9
114.8
257.5
242.8
216.1
184.7
144.9
113.6
143.6
121.1
82.7
31.2
12.3
18.7
-9.1
20.6
19.2
3.4
20
15.4
7.7
4.2

常见问题

什么是 Core Laboratories N.V. (CLB) 总资产是多少?

Core Laboratories N.V. (CLB) 总资产为 586394999.000.

什么是企业年收入?

年收入为 N/A.

企业利润率是多少?

公司利润率为 0.181.

什么是公司自由现金流?

自由现金流为 0.469.

什么是企业净利润率?

净利润率为 0.082.

企业总收入是多少?

总收入为 0.112.

什么是 Core Laboratories N.V. (CLB) 净利润?{{符号}}净利润(净收入)是多少?

净利润(净收入)为 36674999.000.

公司总债务是多少?

债务总额为 215384999.000.

营业费用是多少?

运营支出为 40258999.000.

公司现金是多少?

企业现金为 0.000.